Medical Condition News

RSS

Loyola and Edward Hines receive award to study MBSR in women veterans at risk for heart disease

Loyola University Chicago Marcella Niehoff School of Nursing researchers and Edward Hines, Jr. VA Hospital recently were given an award to study mindfulness-based stress reduction (MBSR) in women veterans at risk for heart disease.

9 May 2013

Nearly 1/10 stroke patients suffer from chronic and debilitating pain

Nearly 1 in 10 stroke patients suffer chronic and debilitating pain, typically described as sharp, stabbing or burning. It's called central poststroke pain syndrome (CPSP). It was first described more than 100 years ago, and it is treatable with medications and magnetic or electrical stimulation of the brain.

9 May 2013

Drug resistant brain tumors: an interview with Prof. Mischel, Ludwig Institute for Cancer Research and Prof. Bensinger, University of California

In cancer, mutations in proteins that control cell growth are common, leading to unrestrained cellular proliferation and tumor formation.

9 May 2013

CEO Roundtable on Cancer recognizes efforts of Methodist Le Bonheur Healthcare

The CEO Roundtable on Cancer recently accredited Methodist Le Bonheur Healthcare with the CEO Cancer Gold Standard, recognizing the health care system's efforts to reduce the risk of cancer for their employees and covered family members by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring access to quality treatment.

9 May 2013

European Patent Office issues notice of intent to grant patent for Nuvo Research's PENNSAID 2%

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain today announced that the European Patent Office has issued a notice of Intention to Grant a European Patent that provides protection for the Company's PENNSAID 2% product.

9 May 2013

Ochsner Medical Center performs Gulf South Region's first implant of SynCardia Total Artificial Heart

When Alfred Williams was admitted to Ochsner Medical Center in December, the 41-year-old father of five had exhausted all treatment options for his enlarged heart. His condition, known as dilated cardiomyopathy, had progressed to end-stage heart failure affecting both sides of his heart. Unable to walk, he had been confined to a bed for months. Hospice care seemed like the only option Mr. Williams had left… until doctors approached him about becoming Ochsner's first patient to receive the SynCardia temporary Total Artificial Heart.

9 May 2013

Synageva BioPharma reports study results of sebelipase alfa in adults with late onset LAL Deficiency

Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare diseases, today reported 12-month results from an ongoing extension study with sebelipase alfa in adults with late onset Lysosomal Acid Lipase Deficiency.

9 May 2013

Clinical study predicting risk of near-term MI and death in CAD patients to be published in JACC

FirstMark, a division of GenWay Biotech that is focused on developing and commercializing noninvasive diagnostic and health monitoring tests for unmet clinical needs, today announced that results from the break-through proof-of-concept clinical study, performed in collaboration with Emory University and MedStar Washington Hospital Center, will be published in the Journal of the American College of Cardiology.

9 May 2013

Abbott receives CE Mark for ARCHITECT HbA1c test

Abbott today announced CE Marking (Conformité Européenne) for the ARCHITECT clinical chemistry Hemoglobin A1c test, which may aid physicians in diagnosing and monitoring diabetes as well as identifying patients at risk for developing diabetes.

9 May 2013

PCB concentrations affect both urban and rural communities, study finds

Since polychlorinated biphenyls are produced through industrial processes or activities, it is assumed that people living in industrial cities will have higher concentrations of these toxic chemicals in their blood than people in rural communities.

9 May 2013

Trevena, Forest sign collaborative agreement to develop TRV027 for treatment of ADHF

Trevena, Inc., a clinical stage pharmaceutical company and the leader in the discovery and development of G-protein coupled receptor biased ligands, and Forest Laboratories Holding Limited, a subsidiary of Forest Laboratories Inc., an international pharmaceutical company, announced today that they have entered into a collaborative licensing option agreement for the development of TRV027, an AT1R biased-ligand that recently completed Phase 2a clinical trials.

9 May 2013

Frequent use of workplace wellness center improves overall quality-of-life

People who used a workplace wellness center on frequent basis reported an improvement in their overall quality-of-life, while those that used the center less often reported no improvements in their physical quality-of-life and a decline in their mental quality-of-life, finds a new study in the American Journal of Health Promotion.

9 May 2013

Loyola opens 20-bed unit for patients undergoing stem cell transplants for cancers

Loyola University Medical Center has opened a new 20-bed unit for patients undergoing stem cell transplants for cancers such as leukemia, lymphoma and multiple myeloma.

9 May 2013

Researchers discover that microRNAs link two defining characteristics of fit muscles

Researchers discovered that small pieces of genetic material called microRNAs link the two defining characteristics of fit muscles: the ability to burn sugar and fat and the ability to switch between slow- and fast-twitch muscle fibers.

9 May 2013

Thijn Brummelkamp wins 2013 EMBO Gold Medal for genetic analysis of human disease

EMBO today announced Thijn Brummelkamp of the Netherlands Cancer Institute in Amsterdam as the winner of the 2013 EMBO Gold Medal. The award acknowledges his outstanding work to accelerate the genetic analysis of human disease.

9 May 2013

Special issue of Gastroenterology presents variety of topics related to pancreas

The editors of Gastroenterology, the official journal of the American Gastroenterological Association Institute, are pleased to announce the publication of this year's highly anticipated special 13th issue.

9 May 2013

CGCF backs Canadian scientist's research on Spinal Muscular Atrophy

The Canadian Gene Cure Foundation, in partnership with the Canadian Institutes of Health Research through its Institute of Genetics, is pleased to announce the awarding of a $90,000 Champions of Genetics: Building the Next Generation Grant to Dr. Faraz Farooq, a Scientist at the Children Hospital of Eastern Ontario Research Institute.

9 May 2013

UA researchers discover genetic mutations that cause severe epilepsies in children

Researchers at the University of Arizona have successfully determined the genetic mutations causing severe epilepsies in seven out of 10 children for whom the cause of the disorder could not be determined clinically or by conventional genetic testing.

9 May 2013

Researchers identify genetic mutations that appear to underlie rare syndrome

Researchers from Massachusetts General Hospital and Duke University have identified genetic mutations that appear to underlie a rare but devastating syndrome combining reproductive failure with cerebellar ataxia - a lack of muscle coordination - and dementia.

9 May 2013

Review for clinicians on optimal utilization of aspirin to treat, prevent heart attacks published

Charles H. Hennekens, M.D., Dr.P.H., the first Sir Richard Doll professor and senior academic advisor to the dean in the Charles E. Schmidt College of Medicine at Florida Atlantic University published a review for clinicians on the optimal utilization of aspirin to treat and prevent heart attacks.

9 May 2013

Medical Condition News

Loyola and Edward Hines receive award to study MBSR in women veterans at risk for heart disease

Nearly 1/10 stroke patients suffer from chronic and debilitating pain

Drug resistant brain tumors: an interview with Prof. Mischel, Ludwig Institute for Cancer Research and Prof. Bensinger, University of California

CEO Roundtable on Cancer recognizes efforts of Methodist Le Bonheur Healthcare

European Patent Office issues notice of intent to grant patent for Nuvo Research's PENNSAID 2%

Ochsner Medical Center performs Gulf South Region's first implant of SynCardia Total Artificial Heart

Synageva BioPharma reports study results of sebelipase alfa in adults with late onset LAL Deficiency

Clinical study predicting risk of near-term MI and death in CAD patients to be published in JACC

Abbott receives CE Mark for ARCHITECT HbA1c test

PCB concentrations affect both urban and rural communities, study finds

Trevena, Forest sign collaborative agreement to develop TRV027 for treatment of ADHF

Frequent use of workplace wellness center improves overall quality-of-life

Loyola opens 20-bed unit for patients undergoing stem cell transplants for cancers

Researchers discover that microRNAs link two defining characteristics of fit muscles

Thijn Brummelkamp wins 2013 EMBO Gold Medal for genetic analysis of human disease

Special issue of Gastroenterology presents variety of topics related to pancreas

CGCF backs Canadian scientist's research on Spinal Muscular Atrophy

UA researchers discover genetic mutations that cause severe epilepsies in children

Researchers identify genetic mutations that appear to underlie rare syndrome

Review for clinicians on optimal utilization of aspirin to treat, prevent heart attacks published

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News